In alignment with previous findings in other tumor types, our results demonstrate that SCD expression is positively correlated with the survival duration of osteosarcoma patients, where its downregulation markedly inhibits osteosarcoma cell proliferation and promotes apoptosis. This evidence concerns the gene SCD and neoplasm.